Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Alpha-synucleinopathies].

I Ferrer1

  • 1Unidad de Neuropatología, Servicio de Anatomía Patológica, Hospital Príncipes de España, Departamento de Biología Celular y Anatomía Patológica, Universidad de Barcelona, Spain. iferrer@sakma.es

Neurologia (Barcelona, Spain)
|June 20, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nuclear pore complex dysfunction drives TDP-43 pathology in ALS.

Redox biology·2025
Same author

A potential therapeutic strategy based on acute oxidative stress induction for wild-type NRF2/KEAP1 lung squamous cell carcinoma.

Redox biology·2024
Same author

Analysis of co-isogenic prion protein deficient mice reveals behavioral deficits, learning impairment, and enhanced hippocampal excitability.

BMC biology·2022
Same author

Mycoplasma genitalium and sexually transmitted infections: evidences and figures in a tertiary hospital.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2021
Same author

Community-based Health Data Cooperatives Towards Improving the Immigrant Community Health: A Scoping Review to Inform Policy and Practice.

International journal of population data science·2020
Same author

Cadaverine and Spermine Elicit Ca<sup>2+</sup> Uptake in Human CP Cells via a Trace Amine-Associated Receptor 1 Dependent Pathway.

Journal of molecular neuroscience : MN·2020
Same journal

[Amyotrophic neuralgia secondary to Vaxzevria (AstraZeneca) COVID-19 vaccine].

Neurologia (Barcelona, Spain)·2024
Same journal

[SARS-CoV-2 infection: Possible underdiagnosis of cerebral venous sinus thrombosis].

Neurologia (Barcelona, Spain)·2024
Same journal

[Bell's palsy following COVID-19 vaccination: A case report].

Neurologia (Barcelona, Spain)·2024
Same journal

[Parsonage-Turner syndrome post-infection by SARS-CoV-2: A case report].

Neurologia (Barcelona, Spain)·2024
Same journal

[Acute transverse myelitis following SARS-CoV-2 infection].

Neurologia (Barcelona, Spain)·2024
Same journal

[Neurological complications in critical patients with COVID-19].

Neurologia (Barcelona, Spain)·2024
See all related articles

Alpha-synucleinopathies are neurodegenerative diseases characterized by abnormal alpha-synuclein protein deposits. While these protein aggregates share common features, their exact impact on cell survival remains unknown.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pathology

Context:

  • Alpha-synucleinopathies encompass a range of disorders including Parkinson's disease, Lewy body dementia, multiple system atrophy, and Alzheimer's disease.
  • These conditions share the common pathological feature of abnormal alpha-synuclein protein aggregation within neuronal and glial cells, and in extracellular amyloid deposits.

Purpose:

  • To define alpha-synucleinopathies based on the commonality of abnormal alpha-synuclein deposition.
  • To differentiate the specific protein aggregates and cellular locations involved in various alpha-synucleinopathies.
  • To highlight the unknown mechanisms and consequences of alpha-synuclein aggregation on cell survival.

Summary:

  • Alpha-synucleinopathies are defined by the abnormal deposition of alpha-synuclein protein, which forms fibrillar aggregates in conditions like Parkinson's disease, Lewy body dementia, and multiple system atrophy.

Related Experiment Videos

  • While alpha-synuclein aggregation is a hallmark, the specific protein interactions and the resulting impact on cell survival across these diverse disorders are not fully understood.
  • The amyloidogenic fragment of alpha-synuclein is also implicated in Alzheimer's disease pathology.

    • Impact:

    • Clarifies the unifying pathological feature of alpha-synucleinopathies.
    • Identifies knowledge gaps regarding the mechanisms of alpha-synuclein aggregation and its cellular consequences.
    • Provides a foundation for future research into the pathogenesis and potential therapeutic targets for alpha-synuclein-related disorders.